<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Herpesviridae and atypical bacteria co-detections in lower respiratory tract samples of SARS-CoV-2-positive patients admitted to an intensive care unit</dc:title><dc:creator>Grubelnik,	Gašper	(Avtor)
	</dc:creator><dc:creator>Korva,	Miša	(Avtor)
	</dc:creator><dc:creator>Kogoj,	Rok	(Avtor)
	</dc:creator><dc:creator>Polanc,	Tina	(Avtor)
	</dc:creator><dc:creator>Mavrič,	Matej	(Avtor)
	</dc:creator><dc:creator>Jevšnik Virant,	Monika	(Avtor)
	</dc:creator><dc:creator>Uršič,	Tina	(Avtor)
	</dc:creator><dc:creator>Keše,	Darja	(Avtor)
	</dc:creator><dc:creator>Seme,	Katja	(Avtor)
	</dc:creator><dc:creator>Petrovec,	Miroslav	(Avtor)
	</dc:creator><dc:creator>Jereb,	Matjaž	(Avtor)
	</dc:creator><dc:creator>Avšič-Županc,	Tatjana	(Avtor)
	</dc:creator><dc:subject>SARS-CoV-2</dc:subject><dc:subject>co-detections</dc:subject><dc:subject>coinfections</dc:subject><dc:subject>lower respiratory tract</dc:subject><dc:subject>ICU</dc:subject><dc:subject>herpesviruses</dc:subject><dc:subject>atypical bacteria</dc:subject><dc:description>Shortly after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cases of viral, bacterial, and fungal coinfections in hospitalized patients became evident. This retrospective study investigates the prevalence of multiple pathogen co-detections in 1472 lower respiratory tract (LRT) samples from 229 SARS-CoV-2-positive patients treated in the largest intensive care unit (ICU) in Slovenia. In addition to SARS-CoV-2, (rt)RT-PCR tests were used to detect cytomegalovirus (CMV), Epstein–Barr virus (EBV), herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-2), varicella zoster virus (VZV), and atypical bacteria: Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila/spp. At least one co-detection was observed in 89.1% of patients. EBV, HSV-1, and CMV were the most common, with 74.7%, 58.1%, and 38.0% of positive patients, respectively. The median detection time of EBV, HSV-1, and CMV after initial SARS-CoV-2 confirmation was 11 to 20 days. Bronchoalveolar lavage (BAL) and tracheal aspirate (TA) samples showed equivalent performance for the detection of EBV, CMV, and HSV-1 in patients with both available samples. Our results indicate that SARS-CoV-2 infection could be a risk factor for latent herpesvirus reactivation, especially HSV-1, EBV, and CMV. However, additional studies are needed to elucidate the clinical importance of these findings.</dc:description><dc:date>2024</dc:date><dc:date>2026-06-12 13:36:44</dc:date><dc:type>Neznano</dc:type><dc:identifier>30063</dc:identifier><dc:identifier>UDK: 578</dc:identifier><dc:identifier>ISSN pri članku: 2076-2607</dc:identifier><dc:identifier>DOI: 10.3390/microorganisms12040714</dc:identifier><dc:identifier>COBISS_ID: 192370691</dc:identifier><dc:language>sl</dc:language></metadata>
